Suppr超能文献

盆腔/腹膜后挽救性淋巴结清扫术用于治疗根治性前列腺切除术后生化复发和 [11C]胆碱正电子发射断层扫描/计算机断层扫描检测到的淋巴结复发的患者。

Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.

机构信息

Department of Urology, Urological Research Institute, University Vita-Salute San Raffaele, Milan, Italy.

出版信息

Eur Urol. 2011 Nov;60(5):935-43. doi: 10.1016/j.eururo.2011.07.060. Epub 2011 Aug 3.

Abstract

BACKGROUND

The management of patients with clinical recurrence of prostate cancer after radical prostatectomy (RP) remains challenging.

OBJECTIVE

To determine whether the removal of positive lymph nodes at [11C]choline positron emission tomography/computed tomography (PET/CT) scan may have an impact on the prognosis of patients with biochemical recurrence (BCR) and nodal recurrence after RP.

DESIGN, SETTING, AND PARTICIPANTS: Prospective analysis of 72 patients affected by BCR after RP associated with a nodal pathologic [11C]choline PET/CT scan.

INTERVENTION

Patients underwent salvage lymph node dissection (LND).

MEASUREMENTS

Biochemical response (BR) to treatment was defined as prostate-specific antigen (PSA) <0.2 ng/ml at 40 d after salvage LND. Kaplan-Meier and Cox regression analyses addressed time to and predictors of clinical recurrence (CR) after salvage LND, respectively.

RESULTS AND LIMITATIONS

Overall, 56.9% of patients achieved BR. Mean and median follow-up after LND were 39.4 and 39.8 mo, respectively. The 5-yr BCR-free survival rate was 19%. Preoperative PSA <4 ng/ml (hazard ratio [HR]: 0.12; p = 0.005), time to BCR <24 mo (HR: 7.52; p = 0.005), and negative lymph nodes at previous RP (HR: 0.19; p=0.04) represented independent predictors of BR. Overall, 5-yr CR-free and cancer-specific survival were 34% and 75%, respectively. At multivariable analyses, only PSA >4 ng/ml (HR: 2.13; p=0.03) and the presence of retroperitoneal uptake at PET/CT scan (HR=2.92; p=0.004) represented independent preoperative predictors of CR. Similarly, the presence of pathologic nodes in the retroperitoneum (HR: 2.78; p=0.02), higher number of positive lymph nodes (HR: 1.04; p=0.006), and complete BR to salvage LND (HR: 0.31; p=0.002) represented postoperative independent predictors of CR. Main limitations consisted of the lack of a control group and the heterogeneity of patients included in the analyses.

CONCLUSIONS

Salvage LND is feasible in patients with BCR after RP and nodal pathologic uptake at [11C]choline PET/CT scan. Biochemical response after surgery can be achieved in a consistent proportion of patients. Although most patients invariably progressed to BCR after surgery at longer follow-up, 35% of patients showed the absence of CR at 5 yr.

摘要

背景

根治性前列腺切除术(RP)后前列腺癌临床复发患者的治疗仍具有挑战性。

目的

确定在 [11C]胆碱正电子发射断层扫描/计算机断层扫描(PET/CT)扫描中阳性淋巴结的清除是否会影响 RP 后生化复发(BCR)和淋巴结复发患者的预后。

设计、地点和参与者:对 72 例因 RP 后出现生化复发并伴有淋巴结病理 [11C]胆碱 PET/CT 扫描的患者进行前瞻性分析。

干预措施

患者接受挽救性淋巴结清扫术(LND)。

测量

以 LND 后 40 d 时前列腺特异性抗原(PSA)<0.2 ng/ml 定义生化反应(BR)。Kaplan-Meier 和 Cox 回归分析分别探讨了挽救性 LND 后临床复发(CR)的时间和预测因素。

结果和局限性

总体而言,56.9%的患者达到 BR。LND 后平均和中位随访时间分别为 39.4 和 39.8 个月。5 年 BCR 无复发生存率为 19%。术前 PSA<4ng/ml(风险比[HR]:0.12;p=0.005)、BCR<24mo(HR:7.52;p=0.005)和 RP 前淋巴结阴性(HR:0.19;p=0.04)是 BR 的独立预测因素。总体而言,5 年 CR 无复发生存率和癌症特异性生存率分别为 34%和 75%。多变量分析仅显示 PSA>4ng/ml(HR:2.13;p=0.03)和 PET/CT 扫描中存在腹膜后摄取(HR=2.92;p=0.004)是 CR 的独立术前预测因素。同样,腹膜后存在病理性淋巴结(HR:2.78;p=0.02)、阳性淋巴结数量较多(HR:1.04;p=0.006)和挽救性 LND 完全 BR(HR:0.31;p=0.002)是 CR 的术后独立预测因素。主要局限性在于缺乏对照组和分析中患者的异质性。

结论

RP 后生化复发且 [11C]胆碱 PET/CT 扫描有淋巴结摄取的患者可行挽救性 LND。手术后可以使相当比例的患者达到生化缓解。尽管大多数患者在更长的随访中最终仍出现生化复发,但 5 年时仍有 35%的患者未出现 CR。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验